20/05/2026
๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐๐๐. ๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐ ๐๐๐.
Copyright May 2026
A diphtheria โoutbreak' has been declared in indigenous communities in Australia and the response, entirely predictably, is a push for vaccination and boosters. So the new pandemic threats didnโt work; apparently grabbing on from the past is exactly what the public have been primed for.
First Nations spokespeople without a background in contagions or immune health are being positioned as the public face of that push, without any knowledge of what is at play. I want to be precise about what the research actually shows, because the public is not being told all of it.
First, the clarification that should be in every media report but is not: COVID-19 boosters provide no protection against diphtheria. Diphtheria is caused by the bacterium Corynebacterium diphtheriae. It has no biological relationship to SARS-CoV-2. A COVID-19 booster administered in response to a diphtheria outbreak is not a protective measure. It is a non-sequitur dressed as public health policy, and any community being encouraged to receive COVID boosters as part of a diphtheria response is being misled, whether intentionally or through the kind of institutional confusion that results when pharmaceutical promotion is mistaken for clinical guidance.
The diphtheria vaccine itself, the DTP or dTPa formulation, has a documented, proven and time-limited efficacy window. Immunity wanes. Vaccinated individuals can carry and transmit the organism asymptomatically. Outbreaks in highly vaccinated populations are documented in the peer-reviewed literature and have occurred in Australia, the United States and across Europe.
Vaccination is not the answer the current media coverage implies, and in communities where nutritional status, immune compromise and environmental health are already significantly below the national average, the conditions that allow diphtheria to take hold are not addressed by a needle alone.
What the media is not reporting is that diphtheria has a two-hundred-year documented history of successful treatment and prevention using homeopathic medicine, with outcomes that in epidemic conditions have consistently exceeded those of allopathic treatment in the published and historical clinical record.
Diphtherinum, the homeopathic nosode prepared from diphtheria toxin, has been used as both a prophylactic and a treatment in diphtheria outbreaks since the late nineteenth century, with practitioners documenting recovery rates and prevention outcomes that the mainstream narrative has chosen to ignore rather than investigate.
The broader homeoprophylaxis evidence base, drawn from large-scale epidemic interventions across multiple countries and multiple conditions over two centuries, is among the most consistent bodies of evidence in complementary medicine and remains almost entirely absent from public health communications.
A 2019 study examining homeoprophylaxis outcomes across a population of 250 million people produced findings that no western regulatory body has seen fit to act upon. Isaac Golden's fifteen-year clinical study on homeoprophylaxis produced a documented efficacy rate of 90.4 percent across 2,342 parent-reported years of data.
The communities now being urged toward vaccination and boosters, including a booster for a completely unrelated virus, deserve to be told that these options exist, that the evidence for them is published and available, and that a government genuinely committed to closing the health gap would be pursuing every documented pathway to protection rather than the one that happens to generate the most pharmaceutical revenue.
๐ซ๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐, ๐๐๐ ๐๐ ๐๐ ๐๐๐๐๐๐๐๐๐. ๐จ๐๐
๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐๐ ๐๐๐๐๐๐
๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐ ๐จ๐ณ๐ณ๐๐ ๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐, ๐๐๐ ๐๐๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐๐ ๐๐๐๐ ๐๐ ๐ ๐๐๐๐๐๐๐๐๐๐-๐๐๐๐๐๐
๐๐๐๐๐๐๐. ๐พ๐๐๐ ๐๐ ๐๐๐๐
๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐ ๐๐๐๐๐ ๐๐๐ ๐๐๐
๐๐๐
๐๐๐
๐๐๐๐๐ ๐
๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐
๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐ ๐
๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐.
๐๐๐
๐๐๐๐๐๐๐: ๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐
๐๐๐๐๐๐๐๐๐๐
๐. ๐๐ผ๐บ๐ฒ๐ผ๐ฝ๐ฎ๐๐ต๐:
๐๐ถ๐๐๐ผ๐ฟ๐ถ๐ฐ๐ฎ๐น ๐๐ผ๐ผ๐ธ๐ & ๐ง๐ฟ๐ฒ๐ฎ๐๐ถ๐๐ฒ๐
โข Helmuth, William Tod. A Treatise on Diphtheria: Its Nature, Pathology and Homoeopathic Treatment. St. Louis Homoeopathic Pharmacy, H.C.G. Luyties, 1864. (Available via University of Michigan Library Digital Collections) University of Michigan
โข Hunt, De Forest. The Homoeopathic Treatment of Diphtheria. Eaton, Lyon & Co., Grand Rapids, Michigan, 1880. (94 pp.) โ Covers pure homoeopathic treatment using the law of similars, with articles on diagnosis and prognosis. nih
โข McNeil, A. A Treatise on Diphtheria: Its History, Etiology, Varieties, Pathology, Sequelae, Diagnosis and Homoeopathic Therapeutics. Duncan Bros., Chicago, 1881. (145 pp.) โ Prize-winning essay; advocates minimal dosing matched to symptom totality. nih
โข Nichol, Thomas. Diphtheria and Its Management. W. Drysdale & Co., Montreal, 1884. (22 pp.) โ No. 1 of the Montreal Tracts on Homoeopathy; written for the laity, comparing homoeopathic and allopathic outcomes. nih
โข Golden, Isaac. Homeoprophylaxis: A Fifteen Year Clinical Study. Gisborne: Isaac Golden Publications, 2004.
โข Coulter, Harris L. Divided Legacy: The Conflict Between Homoeopathy and the American Medical Association. Berkeley: North Atlantic Books, 1973.
โข Ullman, Dana. The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy. Berkeley: North Atlantic Books, 2007.
โข Saine, Andrรฉ. The Theory and Practice of Homeoprophylaxis. Journal of the American Institute of Homeopathy 107, no. 2 (2014).
Journal Articles & Papers
โข Chavanon, P. Laboratory experiment on homeopathic Diphtherinum (4M and 8M potencies) and Schick test results, 1932. Found that one to two months after administering homeopathic Diphtherinum, diphtheria antitoxins were measurable in the blood. Weston A. Price Foundation
โข Patterson, J. and Boyd, W.E. Schick test study on 33 children treated with homeopathic Diphtherinum, 1941. Of 33 children tested, 23 tested negative (indicating the presence of antibodies) after homeopathic treatment. Myupchar
โข Roux, Dr. Replication of the Chavanon/PattersonโBoyd Schick test results, 1947. Similar outcomes were obtained. Myupchar
Modern Reviews & Online Resources
โข National Centre of Homeopathy. Treatment of Epidemics with Homeopathy โ A History. Mount Laurel, NJ. [Online resource] Myupchar
โข Winston, Julian. Some History of the Treatment of Epidemics with Homeopathy. Hpathy.com. โ Includes analysis of Diphtheria records from Broome County, NY (1862โ1864), reporting an 83.6% mortality rate among allopathic physicians versus 16.4% among homeopathic practitioners. Hpathy
โข Bhatia, Manish. Homeopathy for Diphtheria. Hpathy.com, 2023. [hpathy.com/cause-symptoms-treatment/diphtheria/]
๐๐. ๐๐ฒ๐ฟ๐ฏ๐ฎ๐น ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ (๐๐ผ๐๐ฎ๐ป๐ถ๐ฐ๐ฎ๐น / ๐๐ฐ๐น๐ฒ๐ฐ๐๐ถ๐ฐ / ๐ง๐ฟ๐ฎ๐ฑ๐ถ๐๐ถ๐ผ๐ป๐ฎ๐น)
๐๐ฐ๐น๐ฒ๐ฐ๐๐ถ๐ฐ & ๐๐ฒ๐ฟ๐ฏ๐ฎ๐น ๐ง๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐ฃ๐ฎ๐ฝ๐ฒ๐ฟ๐ (๐ญ๐ต๐๐ต ๐๐ฒ๐ป๐๐๐ฟ๐)
โข Thomas, E. Diphtheria. Henriette's Herbal Homepage (sourced from Eclectic texts). โ Details botanical treatments including Echinacea as an antiseptic and sedative, Phytolacca for swollen glands, Baptisia for foul odour, Aconite for fever management, and Hydrastine phosphate for fetor. Henriette's Herbal Homepage
โข Scott, W.A. Diphtheria โ Its Treatment. 1863. โ Describes a throat wash using Golden Seal (Hydrastis canadensis), Black Pepper, Borax, Alum, Nitrate of Potassa, and vinegar, applied locally. nih
โข White, Dr. (reported in Hospital Gazette, 1878). Compound herbal tincture using Cinchona, Capsicum, and Ipecac; reported prompt success in an epidemic. nih
Traditional Chinese & Ayurvedic Medicine
โข Ancient Science of Life (Journal). Treatment of Pharyngeal Diphtheria and Pharyngitis with Traditional Chinese Medicine. Evaluates a compound herbal remedy drawing on TCM clinical experience accumulated since the 18th century, when Western medicine was not yet widely available in China. Wisdom Library
โข National Innovation Foundation (India). Herbal Treatment for Diphtheria. Documents a traditional remedy using Piper nigrum (Black Pepper / Golmirch) fruit and Catharanthus roseus (Sadavati) leaves prepared as a paste, for symptoms including sore throat and fever. [innovation.nif.org.in] Nif
๐๐๐. ๐๐น๐น๐ผ๐ฝ๐ฎ๐๐ต๐ถ๐ฐ / ๐๐ผ๐ป๐๐ฒ๐ป๐๐ถ๐ผ๐ป๐ฎ๐น ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ
๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐๐ถ๐ฑ๐ฒ๐น๐ถ๐ป๐ฒ๐ (๐๐๐ฟ๐ฟ๐ฒ๐ป๐)
โข World Health Organization. Clinical Management of Diphtheria: Guideline. WHO, 2 February 2024. โ Recommends macrolide antibiotics (azithromycin, erythromycin) over penicillin as first-line treatment, with an escalating dosing regimen for Diphtheria Antitoxin (DAT) based on disease severity. [iris.who.int / WHO-DIPH-Clinical-2024.1] Medical Dialogues
Historical Allopathic Literature
โข Ferrand, Dr. (summarizing Paris epidemic experience). Treatment of Diphtheria. L'Union Mรฉdicale, 1879. โ Reviews antiseptic approaches including tannin, salicylate of soda, carbolic camphor, and local applications during a major Parisian diphtheria epidemic. nih
โข Kormann, Ernest. The Treatment of Diphtheria in the Past Eight Years. Coburg, 1882. โ A literature review of nearly 170 contributions on diphtheria treatment, covering prophylaxis, gargling, potassium chlorate, antiseptics, and internal medicines. nih
Modern Peer-Reviewed Research
โข PMC / The Lancet (series). Diphtheria Antitoxin Treatment: From Pioneer to Neglected. PMC, 2025. โ Reviews the WHO 2024 guideline and discusses antimicrobial resistance in C. diphtheriae to penicillin and erythromycin, highly variable across regions and time. PubMed Central
โข Murhekar, M. Epidemiology of Diphtheria in India, 1996โ2016: Implications for Prevention and Control. American Journal of Tropical Medicine and Hygiene, 2017. Vol. 97(2): 313โ318. PMID: 28722581.
โข Kneen, R., Nguyen, M.D., Solomon, T., et al. Clinical Features and Predictors of Diphtheritic Cardiomyopathy in Vietnamese Children. Clinical Infectious Diseases, 2004. 39(11):1591โ8.
๐ผ๐๐ซ๐๐ง๐จ๐ ๐๐๐๐๐๐ฉ๐จ ๐ค๐ ๐ฟ๐๐ ๐๐๐๐๐๐ฃ๐๐จ & ๐พ๐ค๐ฃ๐๐๐ง๐ฃ๐จ ๐ผ๐๐ค๐ช๐ฉ ๐๐ฃ๐ฃ๐๐๐๐จ๐จ๐๐ง๐ฎ ๐ฝ๐ค๐ค๐จ๐ฉ๐๐ง๐จ
๐ฐ. ๐ณ๐๐๐๐ & ๐บ๐๐๐๐๐๐๐ ๐น๐๐๐๐๐๐๐๐๐๐๐๐๐ โ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐๐๐๐ ๐น๐๐๐๐๐ ๐ซ๐๐๐๐
Core Study (Foundational)
โข Cody, C.L., Baraff, L.J., Cherry, J.D., et al. Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children. Pediatrics, 1981. PMID: 7031583. In a prospective study of over 15,000 DTP immunisations in children aged 0โ6 years, minor reactions were significantly more frequent following DTP than DT vaccine. Nine children following DTP immunisation developed convulsions and nine developed hypotonic-hyporesponsive episodes, though no sequelae were detected. PubMed
Increased Local Reactions with Repeat Boosters
โข Reactogenicity and Immunogenicity of Adult vs. Paediatric DiphtheriaโTetanus Booster. Vaccine, 2001. Research comparing booster doses at school-entry age found that large injection site reactions commonly follow booster doses of DTaP vaccines at 4โ6 years of age. Local redness of 50mm or more was noted in 17.2% of children receiving the standard DTaP-IPV booster, with one in five children experiencing large local reactions causing transient discomfort. ScienceDirect
โข Immunogenicity and Safety of a Second Booster Dose of Tdap 10 Years After a First Booster. PMC / Vaccine,2018. [PMC6149833] In a phase III study of a second Tdap booster dose in young adults, any solicited or unsolicited adverse event was reported by 80.6% of Td recipients and 85.6% of Tdap recipients within the 4-day follow-up. Pain was the most frequently reported local adverse event (58.3% and 77.6% respectively). Fatigue and headache were the most common systemic adverse events, reported by approximately 22โ32% of participants. PubMed Central
๐ฐ๐ฐ. ๐ป๐๐ ๐จ๐๐๐๐๐ ๐น๐๐๐๐๐๐๐ โ ๐ฏ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐ ๐ถ๐๐๐-๐ฉ๐๐๐๐๐๐๐
โข Baxter, R., et al. Arthus Reaction as an Adverse Event Following Tdap Vaccination. Vaccines (MDPI), 2020; 8(3):385. PMC7563237. Repeat administration of tetanus toxoid-containing vaccines has been associated with the Arthus phenomenon, a type III immune-complex hypersensitivity reaction. However, the study noted increasing frequency of repeat Tdap administration in adults. MDPIPubMed
โข ScienceDirect โ Arthus Reaction Overview (Immunology & Microbiology): The Arthus reaction has been documented after repeated administration of diphtheria and tetanus anatoxins, particularly in hyperimmunised people. In theory, repeated administration of the same adjuvant in different vaccines could induce high levels of antibody directed toward the adjuvant itself, potentially triggering this reaction. ScienceDirect
๐ฐ๐ฐ๐ฐ. ๐ต๐๐-๐บ๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐ (๐ต๐บ๐ฌ) โ ๐จ๐๐-๐ช๐๐๐๐ ๐ด๐๐๐๐๐๐๐๐ ๐ช๐๐๐๐๐๐๐
โข Aaby, P., Ravn, H., Fisker, A.B., Rodrigues, A., Benn, C.S. Is Diphtheria-Tetanus-Pertussis (DTP) Associated with Increased Female Mortality? A Meta-Analysis Testing the Hypotheses of Sex-Differential Non-Specific Effects of DTP Vaccine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2016; 110(10):570โ581. PMID: 27856947. PMC5155548. In seven studies of BCG-vaccinated children, DTP vaccination was associated with a 2.54-fold increase in mortality in girls (95% CI 1.68โ3.86), with no increase in boys. Oxford AcademicPubMed
โข Benn, C.S. (University of Southern Denmark). Summary of 40 years of research on non-specific vaccine effects. Clinical Microbiology and Infections, 2023. โNo vaccines have been studied for their non-specific effects on overall health, and before we have examined these, we cannot actually determine that the vaccines are safe. In addition, our research shows that some vaccines actually increase overall mortality, especially among girls, and this is very worrying," stated Clinical Professor Christine Stabell Benn. Science News
๐ฐ๐ฝ. ๐พ๐๐๐๐๐ ๐ฐ๐๐๐๐๐๐๐ & ๐ป๐๐ ๐น๐๐๐๐๐๐๐๐ ๐จ๐๐๐๐๐๐ "๐ฑ๐๐๐ ๐๐ ๐ช๐๐๐" ๐ฉ๐๐๐๐๐๐๐
โข Institute of Medicine (US) Vaccine Safety Committee. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Eds. Stratton, K.R., Howe, C.J., Johnston, R.B. National Academy Press, Washington DC, 1994. Covers diphtheria and tetanus toxoid adverse events and examines research strategies for assessing adverse effects associated with vaccines, including central nervous system disorders and other serious events. WHO
๐ฝ. ๐ป๐๐ ๐ช๐๐๐ ๐๐๐ ๐บ๐๐๐๐๐๐๐ ๐ป๐๐๐๐๐๐ ๐ฉ๐๐๐๐๐ ๐ฉ๐๐๐๐๐๐๐
โข Clinical guidance recommends that providers should consider serology testing for tetanus and diphtheria antibodies before administering a tetanus toxoid-containing vaccine, as very high concentrations measured in the blood would support a diagnosis of Arthus risk. ResearchGate
๐๐บ๐ฝ๐ผ๐ฟ๐๐ฎ๐ป๐ ๐ป๐ผ๐๐ฒ: ๐๐ถ๐ฝ๐ต๐๐ต๐ฒ๐ฟ๐ถ๐ฎ ๐ถ๐ ๐ฎ ๐๐ฒ๐ฟ๐ถ๐ผ๐๐, ๐ฝ๐ผ๐๐ฒ๐ป๐๐ถ๐ฎ๐น๐น๐ ๐ณ๐ฎ๐๐ฎ๐น ๐ฏ๐ฎ๐ฐ๐๐ฒ๐ฟ๐ถ๐ฎ๐น ๐ถ๐ป๐ณ๐ฒ๐ฐ๐๐ถ๐ผ๐ป. ๐ง๐ต๐ฒ๐ฟ๐ฒ ๐ฎ๐ฟ๐ฒ ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐ฐ๐ฒ-๐ฏ๐ฎ๐๐ฒ๐ฑ ๐ฐ๐๐ฟ๐ฎ๐๐ถ๐๐ฒ ๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐๐. ๐๐ถ๐๐๐ผ๐ฟ๐ถ๐ฐ๐ฎ๐น ๐ต๐ผ๐บ๐ฒ๐ผ๐ฝ๐ฎ๐๐ต๐ถ๐ฐ ๐ฎ๐ป๐ฑ ๐ต๐ฒ๐ฟ๐ฏ๐ฎ๐น ๐ฟ๐ฒ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ๐ ๐ฎ๐ฟ๐ฒ ๐ถ๐ป๐ฐ๐น๐๐ฑ๐ฒ๐ฑ ๐ต๐ฒ๐ฟ๐ฒ ๐ณ๐ผ๐ฟ ๐๐ฐ๐ต๐ผ๐น๐ฎ๐ฟ๐น๐ ๐ฎ๐ป๐ฑ ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ฟ๐ฎ๐๐ถ๐๐ฒ ๐ฝ๐๐ฟ๐ฝ๐ผ๐๐ฒ๐ ๐ฎ๐ป๐ฑ ๐๐ต๐ผ๐๐น๐ฑ ๐ป๐ผ๐ ๐ฏ๐ฒ ๐๐๐ฒ๐ฑ ๐ฎ๐ ๐ฎ ๐๐๐ฏ๐๐๐ถ๐๐๐๐ฒ ๐ณ๐ผ๐ฟ ๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฐ๐ฎ๐ฟ๐ฒ.